Compound Detail
CHEMBL1921847
ATICAPRANT 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL1921847 |
| Name | ATICAPRANT |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | ZHPMYDSXGRRERG-DEOSSOPVSA-N |
3
Targets
7
Activities
1
Assay Types
28
PK Parameters
20
Publications
8
Known Names
4
Indications
1
Mechanisms
Molecular Properties
418.5
MW (Da)
5.67
ALogP
3
HBA
1
HBD
55.6
PSA (Ų)
0.56
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Kappa opioid receptor antagonist | ANTAGONIST | Kappa-type opioid receptor | ✓ | ✓ |
Indications
Depressive Disorder, Major Depressive Disorder, Treatment-Resistant Tobacco Use Disorder Anxiety
Activity Summary
Ki 7 meas. best 9.22
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Kappa-type opioid receptor CHEMBL237 | Ki | 9.22 | 9.1133 | 0.6 | 3 |
| Mu-type opioid receptor CHEMBL233 | Ki | 7.79 | 7.715 | 16.4 | 2 |
| Delta-type opioid receptor CHEMBL236 | Ki | 6.91 | 6.845 | 122.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 186.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 466.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 186.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 466.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 89.3 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 89.3 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 798.07 | nM | Rattus norvegicus |
| Cmax | 227.0 | nM | Rattus norvegicus |
| Cmax | 798.07 | nM | Rattus norvegicus |
| Cmax | 227.0 | nM | Rattus norvegicus |
| F | 25.4 | % | Rattus norvegicus |
| F | 25.0 | % | Rattus norvegicus |
| F | 25.4 | % | Rattus norvegicus |
| F | 25.0 | % | Rattus norvegicus |
| T1/2 | 1.8 | hr | Rattus norvegicus |
| T1/2 | 3.8 | hr | Rattus norvegicus |
| T1/2 | 2.0 | hr | Rattus norvegicus |
| T1/2 | 1.8 | hr | Rattus norvegicus |
| T1/2 | 3.8 | hr | Rattus norvegicus |
| T1/2 | 1.8 | hr | Rattus norvegicus |
| T1/2 | 3.8 | hr | Rattus norvegicus |
| T1/2 | 21.0 | hr | Homo sapiens |
| Tmax | - | hr | Rattus norvegicus |
| Tmax | 2.0 | hr | Rattus norvegicus |
| Tmax | 1.0 | hr | Rattus norvegicus |
| Tmax | - | hr | Rattus norvegicus |
| Tmax | 2.0 | hr | Rattus norvegicus |
| Tmax | 1.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Kappa-type opioid receptor | Ki | = | 0.597 | nM | 9.22 | Binding affinity to human cloned KOR in presence of Na+/GDP | 23360448 |
| Kappa-type opioid receptor | Ki | = | 0.8 | nM | 9.1 | Antagonist activity at kappa opioid receptor (unknown origin) | 25513968 |
| Kappa-type opioid receptor | Ki | = | 0.949 | nM | 9.02 | Displacement of [3H]diprenorphine from human opioid kappa receptor expressed in ... | 21958337 |
| Mu-type opioid receptor | Ki | = | 16.4 | nM | 7.79 | Binding affinity to human cloned MOR in presence of Na+/GDP | 23360448 |
| Mu-type opioid receptor | Ki | = | 22.7 | nM | 7.64 | Displacement of [3H]diprenorphine from human opioid mu receptor expressed in CHO... | 21958337 |
| Delta-type opioid receptor | Ki | = | 122.0 | nM | 6.91 | Binding affinity to human cloned DOR in presence of Na+/GDP | 23360448 |
| Delta-type opioid receptor | Ki | = | 166.0 | nM | 6.78 | Displacement of [3H]diprenorphine from human opioid delta receptor expressed in ... | 21958337 |
Literature References
Data from ChEMBL 36 via Core Engine